A new study led by investigators from Mass General Cancer Center, a founding member of the Mass General Brigham healthcare system, reveals that statins-;commonly used cholesterol-lowering drugs-;may block a particular pathway involved in the development of cancer that results from chronic inflammation.
Statins may block an inflammation pathway involved in the development of cancer
- Post author:
- Post published:May 30, 2024
- Post category:uncategorized